The results of the MTT test in this study showed that, in cancer cells with knocked out uPAR, IC50 of chemotherapy drugs, including 5-FU, cisplatin, docetaxel, and doxorubicin, was significantly reduced, indicating drug resistance attenuation and enhancement of cancer cells’ chemosensitivity [119]. The gene discussed is PLAUR; the disease is cancer.